Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2011.08.007PMID 21880354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies.

  2011influential reference
• Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

  2011cited by this paper
• Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.

  2011cited by this paper
• Mechanical properties of the esophagus in eosinophilic esophagitis.

  2011cited by this paper
• Managing Asthma: An Evidence-Based Approach to Optimizing Inhaled Corticosteroid Treatment

  2010cited by this paper
• CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis

  2010cited by this paper
• Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.

  2010influential reference
• Fluticasone and Food Allergen Elimination Reverse Sub-epithelial Fibrosis in Children with Eosinophilic Esophagitis

  2010cited by this paper
• An update on the immunopathogenesis of eosinophilic esophagitis

  2010cited by this paper
• IL-13 Induces Esophageal Remodeling and Gene Expression by an Eosinophil-Independent, IL-13Rα2–Inhibited Pathway

  2010influential reference
• Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids

  2010influential reference
• Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum.

  2009cited by this paper
• The natural history and complications of eosinophilic esophagitis.

  2008cited by this paper
• FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis

  2008cited by this paper
• Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia.

  2008cited by this paper
• Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma.

  2008cited by this paper
• Treatment With Topical Steroids Downregulates IL-5, Eotaxin-1/CCL11, and Eotaxin-3/CCL26 Gene Expression in Eosinophilic Esophagitis

  2008influential reference
• Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series.

  2007cited by this paper
• Esophageal remodeling in pediatric eosinophilic esophagitis.

  2007influential reference
• CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.

  2007cited by this paper
• Esophageal Subepithelial Fibrosis in Children With Eosinophilic Esophagitis

  2007cited by this paper
• Involvement of CCL18 in allergic asthma.

  2006cited by this paper
• A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.

  2006cited by this paper
• Involvement of CCL18 in Allergic Asthma1

  2006cited by this paper
• PKCα Mediates CCL18-Stimulated Collagen Production in Pulmonary Fibroblasts

  2006cited by this paper
• CCL18‐stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity

  2006cited by this paper
• PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts.

  2006cited by this paper
• CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes.

  2006cited by this paper
• CCL18 Is Expressed in Atopic Dermatitis and Mediates Skin Homing of Human Memory T Cells

  2005cited by this paper
• Topical viscous budesonide suspension for treatment of eosinophilic esophagitis.

  2005cited by this paper
• Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages.

  2004cited by this paper
• Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids

  2004cited by this paper
• Natural history of primary eosinophilic esophagitis: a follow up of 30 adult patients for up to 11.5 years.

  2004cited by this paper
• Transforming Growth Factor- b(TGF- b )シグナル伝達の制御機構と疾患

  2004cited by this paper
• IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent

  2004cited by this paper
• Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression.

  2003cited by this paper
• Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years.

  2003cited by this paper
• Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts.

  2003cited by this paper
• Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.

  2001cited by this paper
• Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

  1999cited by this paper
• Human Eosinophils Regulate Human Lung- and Skin-Derived Fibroblast Properties in vitro: A Role for Transforming Growth Factor β (TGF-β)

  1999cited by this paper
• Treatment of eosinophilic esophagitis with inhaled corticosteroids.

  1998cited by this paper
• Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.

  1997cited by this paper
• Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid.

  1997cited by this paper
• Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

  1994cited by this paper

• Personalization of therapy for patients with eosinophilic esophagitis

  2025cites this paper
• Dilation in EoE: Still Necessary?

  2025cites this paper
• INSIGHTS INTO THE NATURAL HISTORY AND DISEASE COURSE OF EOSINOPHILIC ESOPHAGITIS.

  2025cites this paper
• Pharmacologic Management of Eosinophilic Esophagitis.

  2024cites this paper
• Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties

  2024influential citation
• Pathophysiology and Clinical Impact of Esophageal Remodeling and Fibrosis in Eosinophilic Esophagitis.

  2024cites this paper
• Esophageal remodeling in eosinophilic esophagitis

  2024cites this paper
• Amphiregulin-producing TH2 cells facilitate esophageal fibrosis of eosinophilic esophagitis

  2024cites this paper
• Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms

  2023cites this paper
• Challenges in Inter-rater Agreement on Lamina Propria Fibrosis in Esophageal Biopsies

  2023cites this paper
• Breaking down the complex pathophysiology of eosinophilic esophagitis.

  2022cites this paper
• Clinical Guidance for the Use of Dupilumab in Eosinophilic Esophagitis: A Yardstick.

  2022cites this paper
• Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets

  2022cites this paper
• Fibrotic remodeling and tissue regeneration mechanisms define the therapeutic potential of human muscular progenitors

  2022cites this paper
• Current treatment options and long-term outcomes in patients with eosinophilic esophagitis

  2022cites this paper
• Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management

  2022cites this paper
• A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide

  2022cites this paper
• Role of fibroblast growth factor signalling in hepatic fibrosis

  2021cites this paper
• Eosinophilic esophagitis—established facts and new horizons

  2021cites this paper
• Eosinophils Correlate with Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis with Nasal Polyps

  2021cites this paper
• Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic Esophagitis

  2021cites this paper
• Eosinophilic Esophagitis and Microbiota: State of the Art

  2021cites this paper
• Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults

  2021cites this paper
• Gene therapy for a murine model of eosinophilic esophagitis

  2021cites this paper
• Clinical-Pathological Conference Series from the Medical University of Graz

  2020cites this paper
• Red Between the Lines: Evolution of Eosinophilic Esophagitis as a Distinct Clinicopathologic Syndrome

  2020cites this paper
• Treatment of eosinophlic esophagitis with swallowed topical corticosteroids

  2020cites this paper
• Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

  2020cites this paper
• Recent insights on the use of topical steroids in eosinophilic esophagitis

  2020cites this paper
• An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results.

  2020cites this paper
• Eosinophilic esophagitis in children – current state of the problem

  2020cites this paper
• Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.

  2020cites this paper
• CD4+ T cells and TGFβ1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease.

  2020cites this paper
• Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis

  2019cites this paper
• Esophageal perforation in eosinophilic esophagitis: A systematic review on clinical presentation, management and outcomes.

  2019cites this paper
• Eosinophilic Esophagitis—A Primer for Otolaryngologists

  2019cites this paper
• Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review

  2019cites this paper
• Epidemiology, etiology and pathogenesis of eosinophilic esophagitis. The latest data

  2019influential citation
• Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results

  2019cites this paper
• Intramural esophageal dissection. A rare occurrence in pediatric eosinophilic esophagitis.

  2018cites this paper
• Эозинофильные поражения желудка и кишечника: клиника, диагностика, лечение

  2018cites this paper
• Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms

  2018cites this paper
• Eosinophilic disorders of the gastrointestinal tract: clinical manifestations, diagnosis and treatment

  2018cites this paper
• Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management.

  2018cites this paper
• Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis

  2018cites this paper
• Medical and dietary treatments in eosinophilic esophagitis.

  2018cites this paper
• Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice

  2018cites this paper
• Eosinophilic Esophagitis in Children and Adults.

  2018cites this paper
• Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms

  2018cites this paper
• Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists

  2018cites this paper
• Understanding fibrosis in eosinophilic esophagitis: Are we there yet?

  2018cites this paper
• Esophageal dilation in eosinophilic esophagitis: risks, benefits, and when to do it

  2018cites this paper
• Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response

  2018cites this paper
• Pathophysiology of Eosinophilic Esophagitis

  2018influential citation
• The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy

  2017cites this paper
• Eosinophilic esophagitis: What can we learn from Crohn’s disease?

  2017cites this paper
• Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis

  2017cites this paper
• Novel immunologic mechanisms in eosinophilic esophagitis.

  2017cites this paper
• Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives

  2017cites this paper
• Eosinophile Ösophagitis – Neues zur Pathogenese, Diagnostik und Therapie

  2017cites this paper
• Specific locations of linear furrows in patients with esophageal eosinophilia

  2017cites this paper
• Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression

  2017cites this paper
• Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.

  2017cites this paper
• White Paper AGA: Drug Development for Eosinophilic Esophagitis

  2017cites this paper
• Diagnosis and treatment of eosinophilic esophagitis in clinical practice

  2017cites this paper
• Pathophysiology of Eosinophilic Esophagitis.

  2017cites this paper
• Clinical-Pathological Conference Series from the Medical University of Graz

  2017cites this paper
• Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis.

  2017cites this paper
• Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.

  2017cites this paper
• A novel role for the TRAIL signalling pathway in the pathogenesis of Eosinophilic Oesophagitis

  2017cites this paper
• TGF-β1 Alters Esophageal Epithelial Barrier Function by Attenuation of Claudin-7 in Eosinophilic Esophagitis

  2017cites this paper
• Eosinophilic Oesophagitis in Children: Disease Modulation by Topical Steroids

  2017cites this paper
• Eosinophilic esophagitis: update on management and controversies

  2017cites this paper
• Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis

  2017cites this paper
• White Paper AGA: Eosinophilic esophagitis

  2017cites this paper
• A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults

  2017cites this paper
• Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype

  2016cites this paper
• Eosinophilic Esophagitis: An Evidence-Based Approach to Therapy.

  2016cites this paper
• Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis

  2016cites this paper
• Mechanisms of Disease of Eosinophilic Esophagitis.

  2016cites this paper
• TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.

  2016cites this paper
• The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video).

  2016cites this paper
• Eosinophilic disorders of the gastro-intestinal tract: an update

  2016cites this paper
• Eosinophilic esophagitis: current perspectives from diagnosis to management

  2016cites this paper
• JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE

  2016cites this paper
• Causes and Outcomes of Esophageal Perforation in Eosinophilic Esophagitis

  2016cites this paper
• Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter

  2016cites this paper
• Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior

  2016cites this paper
• Pharmacological treatment of eosinophilic gastrointestinal disorders

  2016cites this paper
• Eosinophilic esophagitis: New insights in pathogenesis and therapy.

  2016cites this paper
• Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis

  2016cites this paper
• Eosinophilic Esophagitis: A Comprehensive Review

  2016cites this paper
• The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis.

  2016cites this paper
• Recent discoveries and emerging therapeutics in eosinophilic esophagitis.

  2016cites this paper
• Eosinophilic Esophagitis: A Comprehensive Review

  2016cites this paper
• 45 – Allergic and Eosinophilic Gastrointestinal Disease

  2016cites this paper
• Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.

  2016cites this paper
• Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.

  2016influential citation
• TGFβ1-Induced PAI-1 Contributes to a Pro-Fibrotic Network in Eosinophilic Esophagitis

  2016cites this paper
• The Extreme Narrow-Caliber Esophagus is a Treatment Resistant Sub-Phenotype of Eosinophilic Esophagitis

  2016cites this paper